Are conventional cardiovascular risk factors predictive of two-year mortality in hemodialysis patients?

被引:0
|
作者
Fleischmann, EH [1 ]
Bower, JD [1 ]
Salahudeen, AK [1 ]
机构
[1] Univ Mississippi, Med Ctr, Dept Med, Div Renal, Jackson, MS 39216 USA
关键词
hyperlipidemia; hypertension; obesity; hemodialysis; survival; risk factors;
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background: In general population hypertension, diabetes mellitus, overweight, hyperlipidemia and smoking are well-established risk factors for cardiovascular disease. However, the effect of these conventional risk factors on cardiovascular disease and mortality of patients on hemodialysis is not well understood. Indeed, some risk factors such as high blood pressure, hyperlipidemia and excess weight have been recently claimed to correlate with improved survival. Objective: This study was undertaken to define the prevalence of these conventional risk factors in 453 hemodialysis patients, predominantly African-Americans, to determine their influence on two-year survival. Result: High cholesterol was found in 30% of the patients, high LDL-cholesterol in 25% and high triglycerides in 16%. Lipoprotein(a) (LP(a)) was elevated in 68% of the patients. 31% of our patients had predialysis mean arterial blood pressure (MAP) over 114, and 25% were obese based on a body mass index (BMI) over 30, 26% were diabetic and 25% were active smokers. Smoking was more common among our male and Caucasian patients. The aggregate score for the risk factors were 2.4 +/- 0.1 per patient, which increased to 3.2 +/- 0.1 in patients with obesity or diabetes, to 3.0 +/- 0.1 with hypertension and to 2.8 +/- 0.1 with active smoking. In multivariate Cox model analysis, prealbumin, body weight and blood pressure showed a positive correlation with two-year survival whereas diabetes mellitus had a negative correlation. Hyperlipidemia did not correlate to patients' two-year mortality. Smoking was associated with higher mortality, but that did not reach statistical significance. Conclusion: Conventional risk factors at least over a two-year period do not readily account for the higher mortality of a group of predominantly African-American patients on hemodialysis. The lack of prediction is speculated to be partly due to the overriding beneficial effects of better nutrition and due to the presence of other yet to be well-defined factors such as hyperhomocysteinemia, oxidative stress, coronary calcification, hitherto unidentified uremic toxins or a combination of these factors.
引用
收藏
页码:221 / 230
页数:10
相关论文
共 50 条
  • [1] Risk Factors for Mortality in Hemodialysis Patients: Two-Year Follow-Up Study
    do Sameiro-Faria, Maria
    Ribeiro, Sandra
    Costa, Elisio
    Mendonca, Denisa
    Teixeira, Laetitia
    Rocha-Pereira, Petronila
    Fernandes, Joao
    Nascimento, Henrique
    Kohlova, Michaela
    Reis, Flavio
    Amado, Leonilde
    Bronze-da-Rocha, Elsa
    Miranda, Vasco
    Quintanilha, Alexandre
    Belo, Luis
    Santos-Silva, Alice
    [J]. DISEASE MARKERS, 2013, 2013 : 791 - 798
  • [2] Risk Factors Associated with Cardiovascular Morbidity and Mortality in Spanish Incident Hemodialysis Patients: Two-Year Results from the ANSWER Study
    Cuevas, Xavier
    Garcia, Fernando
    Martin-Malo, Alejandro
    Fort, Joan
    Llados, Fina
    Lozano, Javier
    Perez-Garcia, Rafael
    [J]. BLOOD PURIFICATION, 2012, 33 (1-3) : 21 - 29
  • [3] Hemodialysis-associated hypotension as an independent risk factor for two-year mortality in hemodialysis patients
    Shoji, T
    Tsubakihara, Y
    Fujii, M
    Imai, E
    [J]. KIDNEY INTERNATIONAL, 2004, 66 (03) : 1212 - 1220
  • [4] Uremic Pruritus is Associated with Two-Year Cardiovascular Mortality in Long Term Hemodialysis Patients
    Weng, Cheng-Hao
    Hu, Ching-Chih
    Yen, Tzung-Hai
    Hsu, Ching-Wei
    Huang, Wen-Hung
    [J]. KIDNEY & BLOOD PRESSURE RESEARCH, 2018, 43 (03): : 1000 - 1009
  • [5] Brain Natriuretic Peptide between Traditional and Nontraditional Risk Factors in Hemodialysis Patients: Analysis of Cardiovascular Mortality in a Two-Year Follow-Up
    Selim, G.
    Stojceva-Taneva, O.
    Spasovski, G.
    Georgievska-Ismail, L.
    Zafirovska-Ivanovska, B.
    Gelev, S.
    Dzekova, P.
    Trajcevska, L.
    Trojacanec-Piponska, S.
    Sikole, A.
    [J]. NEPHRON CLINICAL PRACTICE, 2011, 119 (02): : C162 - C170
  • [6] Soluble CD40 ligand is predictive of cardiovascular morbidity and mortality in patients on hemodialysis at two-year follow-up
    Ghiadoni, L.
    Panichi, V.
    Paoletti, S.
    Panicucci, E.
    Bigazzi, R.
    Antonelli, A.
    Palla, R.
    Rindi, P.
    Aloisi, M.
    Passacquale, G.
    Taddei, S.
    Ferri, C.
    Mezzetti, A.
    Cipollone, F.
    Desideri, G.
    [J]. JOURNAL OF HYPERTENSION, 2007, 25 : S141 - S141
  • [7] Global and Cardiovascular Mortality and Risk Factors in Patients Under Hemodialysis Treatment
    Almeida, Fatima Aparecida A.
    Machado, Felipe Carrha
    Moura Junior, Jose Andrade
    Guimaraes, Armenio Costa
    [J]. ARQUIVOS BRASILEIROS DE CARDIOLOGIA, 2010, 94 (02) : 201 - 206
  • [8] A two-year analysis of risk factors and outcome in patients with bloodstream infection
    Endimiani, A
    Tamborini, A
    Luzzaro, F
    Lombardi, G
    Toniolo, A
    [J]. JAPANESE JOURNAL OF INFECTIOUS DISEASES, 2003, 56 (01) : 1 - 7
  • [9] Predictive factors of cardiovascular disease in patients on maintenance hemodialysis
    Danis, Ramazan
    Ozmen, Sehmus
    Akin, Davut
    Celik, Fatma
    Yazanel, Orhan
    [J]. DIALYSIS & TRANSPLANTATION, 2008, 37 (02) : 58 - +
  • [10] Combining Novel Biomarkers for Risk Stratification of Two-Year Cardiovascular Mortality in Patients with ST-Elevation Myocardial Infarction
    Zagidullin, Naufal
    Motloch, Lukas J.
    Gareeva, Diana
    Hamitova, Aysilu
    Lakman, Irina
    Krioni, Ilja
    Popov, Denis
    Zulkarneev, Rustem
    Paar, Vera
    Kopp, Kristen
    Jirak, Peter
    Ishmetov, Vladimir
    Hoppe, Uta C.
    Tulbaev, Eduard
    Pavlov, Valentin
    [J]. JOURNAL OF CLINICAL MEDICINE, 2020, 9 (02)